Sources of Funding: This study was self-funded.
Adverse effects of rifampicin in dogs and serum alanine aminotransferase monitoring recommendations based on a retrospective study of 344 dogs
Article first published online: 28 OCT 2013
© 2013 ESVD and ACVD
Volume 24, Issue 6, pages 570–e136, December 2013
How to Cite
Bajwa, J., Charach, M. and Duclos, D. (2013), Adverse effects of rifampicin in dogs and serum alanine aminotransferase monitoring recommendations based on a retrospective study of 344 dogs. Veterinary Dermatology, 24: 570–e136. doi: 10.1111/vde.12083
Conflict of Interest: No conflicts of interest have been declared.
- Issue published online: 21 NOV 2013
- Article first published online: 28 OCT 2013
- Manuscript Accepted: 27 JUN 2013
|vde12083-sup-0001-TableS1.xlsx||application/msexcel||15K||Table S1. Details of adverse events in 56 dogs on rifampicin therapy.|
|vde12083-sup-0002-TableS2.docx||Word document||14K||Table S2. Summary of concurrent drugs used with rifampicin therapy.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.